Akeso, Inc. (HKEX: 9926.HK) published the preclinical research data for its novel antagonistic monoclonal antibody targeting IL-1RAP, AK135, at the 40th Annual Meeting of the Society for Immunotherapy ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...

INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

HONG KONG, Nov 6, 2025 - (ACN Newswire) – On October 29 local time, the Federal Reserve launched its fifth interest rate cut ...

During a session at the 2025 LeadingAge Annual Meeting in Boston, industry leaders discussed the importance of data sharing ...

A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...

CEO Wenbin Jiang highlighted that "total revenue reached $52.3 million, representing a year-over-year increase of 2% compared to the same period in 2024." Jiang emphasized strong double-digit gains in ...

Cullinan Therapeutics (CGEM) announced new clinical data from its Phase 1 study of CLN-049 ... bone marrow blasts less than5%, 33% patients were MRD negative by flow cytometry; relapse was not ...

DiffusionData, a provider of a secure, real-time data server, is introducing an open source implementation of the Model Context Protocol (MCP) that lets AI assistants interact with Diffusion in ...

Data-driven AI delivering meaningful RCM impact helps health systems reduce denials and streamline payer-provider workflows in real time.